NICE recommended Opdivo as post-surgery treatment
The therapy will be used for specific muscle invasive urothelial cancer patients Bristol Myers Squibb has announced that the National Institute for Health and Care Excellence (NICE) has issued a final appraisal determination recommending Opdivo (n...
See more